Ceftralin-S 1gm/0.5gm Injection
By Ceftralin-S
Rx
1 Powder for Injection in a Vial

Composition
Ceftriaxone(1gm) + Sulbactam(0.5gm)

Manufacturer - Medilente Pharma Pvt Ltd
Medilente Pharma Pvt Ltd., Rahul Rawat (Executive Director), PLot No. 357-A, Ist Floor, Industrial Area, Phase -1, Panchkula (Haryana)

Expires on or after
August, 2025

liver
When using Ceftralin-S 1gm/0.5gm Injection, it is essential to exercise caution in patients with severe liver disease. In such cases, dose adjustment of the medication may be necessary, and it is crucial to consult your doctor regarding the appropriate dosage. However, for patients with mild to moderate liver disease, dose adjustment of Ceftralin-S 1gm/0.5gm Injection is generally not recommended. It is important to follow your doctor's guidance closely to ensure the safe and effective use of this medication.

kidney
Caution Limited data on Ceftralin-S 1gm/0.5gm Injection use in kidney disease patients. Consult your doctor.

alcohol
It is safe to consume alcohol with Ceftralin-S 1gm/0.5gm Injection as it does not result in any adverse effects.

driving
When using Ceftralin-S 1gm/0.5gm Injection, it can reduce alertness, impact vision, and cause drowsiness and dizziness. Therefore, avoid driving if experiencing these effects.

pregnancy
Ceftralin-S 1gm/0.5gm Injection is generally considered safe during pregnancy based on animal studies showing minimal adverse effects on the baby. Limited human studies are available, so consult your doctor before use.

breastfeeding
During breastfeeding, caution is advised when using Ceftralin-S 1gm/0.5gm Injection. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹128
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025